Contact information for researchers and applicants

Vrouw met headset

Grant Management Team

If you have any questions, please contact our Grant Management Team. They are happy to help you with the administrational procedures regarding your grant application or ongoing research project. They can also refer you to one of our Programme Coordinators who supervise our research projects by research theme.

T: +31 20 - 570 04 50
bestedingen@kwf.nl 

Programme Coordinator Team

Jasmijn Span, MSc - Basic Research 

Scientific research aimed at obtaining insight into the origin and progression of cancer, its (psychosocial) effects, as well as basic principles of prevention and treatment of cancer and relevant technological developments. Basic research does not directly focus on the possible application of this knowledge.  

Christina Stangl, PhD - Basic Research 

Scientific research aimed at obtaining insight into the origin and progression of cancer, its (psychosocial) effects, as well as basic principles of prevention and treatment of cancer and relevant technological developments. Basic research does not directly focus on the possible application of this knowledge.  

Lenno Krenning, PhD - Basic Research 

Scientific research aimed at obtaining insight into the origin and progression of cancer, its (psychosocial) effects, as well as basic principles of prevention and treatment of cancer and relevant technological developments. Basic research does not directly focus on the possible application of this knowledge.

Marion Scharpfenecker, PhD - Biomarkers

Biomarkers are characteristics that are objectively measured and evaluated as an indicator for cancer risk, the presence of a specific cancer or recurrent cancer, the stage or severity of a specific cancer, and how well the patient responds to therapeutic intervention(s).  

Maud Plantinga, PhD - Biomarkers

Biomarkers are characteristics that are objectively measured and evaluated as an indicator for cancer risk, the presence of a specific cancer or recurrent cancer, the stage or severity of a specific cancer, and how well the patient responds to therapeutic intervention(s).

Sigrid Oomen, PhD - Interventive Devices 

Treatment instruments to prevent or treat local-regional sites of cancer or precancerous lesions. The modalities may be delivered non-invasively (e.g. radiation therapy), minimally invasively (e.g.cryoablation, hyperthermia) or by open surgery (invasive).

Bas Pouw, PhD - Imaging

Scientific research into imaging includes various types of techniques to obtain detailed pictures of areas inside the body, such as magnetic fields (MRI), X-rays (CT), ultrasound (echography) and radioactive substances (PET) for functional imaging. Imaging is used to detect early stage cancer, diagnose disease, plan treatment or assess therapeutic response.

Kevin Kos, PhD - Immunotherapy

Immunotherapy is a cancer treatment that helps the patient’s own immune system to recognize and destroy cancer cells. Examples are monoclonal antibodies (drugs that counteract immune suppression or mark cancer cells for destruction), cytokines (small proteins that regulate immune responses) and therapeutic vaccines.

Eveline Noteboom, PhD - Implementation

Research on methods to facilitate the implementation of concrete applications (with demonstrable added value compared to the current practice) into national oncology policy and practice. Focus on the actions of healthcare professionals and other stakeholders as a key variable in the sustainable implementation of evidence-based interventions.

Delphi Coppens, PhD - Cell & Gene Therapy

Cell therapy is the transfer of living cells into a patient to treat cancer. It usually involves immune cells that have been modified to recognize and destroy cancer cells (e.g. dendritic cell vaccination or CAR T-cell therapy). Gene therapy is transfering genetic material into a patient and alterating the genetic code to treat cancer.

Mai Tran, MSc - Infrastructure

Infrastructural initiatives provide services, resources and networks to support cancer research. These initiatives enable the research community to address specific research questions and thereby help accelerate and/or optimise the exploitation of results to the patients and public. 

Maaike Kuijpers, MSc - Clinical trials

Clinical trials are research studies performed in people to find out if new diagnostic methods and treatments are safe and effective. KWF supports researchers in conducting their trials and disseminating and implementing their results.

Lotte Reinhoudt, MSc - Side effects & Research Methodology

This portfolio focusses on KWF-projects in which side effects of medical procedures (e.g. pharmacotherapy) are the primary outcome measure and/or in which innovative research methodologies are used.

Tessa Nauta, PhD - Agents

Drugs or biologicals used to prevent or inhibit the proliferation of cancerous cells. Examples of agents are small molecules, therapeutic enzymes and hormones.

Janneke van Doorn, MSc - Lifestyle and Exposure

Lifestyle & Exposure is the influence of behaviour or exposure to exogenous factors on the development, recurrence, aggravation or prevention of (side effects of) cancer (treatment). 

Quirien Oort, MSc - Quality of Life & Quality of Care

Quality of life encompasses all aspects of well-being, including functional, social, societal, psychological, emotional and existential problems in (ex)patients and their caregivers. Quality of care is aimed at providing the most appropriate oncological care according to the needs of each individual patient, developing and implementing national best practice guidelines and improving healthcare communication.